Prevalence of cervical cancer and feasibility of screening in rural China: A pilot study for the Shanxi Province Cervical Cancer Screening Study

International Journal of Gynecological Cancer

Volumn 9, Issue 5, 1999, Pages 411-417

  Belinson, J ^a   Qiao, Y ^b   Pretorius, R ^c   Zhang, W ^b   Keaton, K ^a   Elson, P ^a   Fischer, C ^d   Lorincz, A ^e   Zahniser, D ^f   Wilbur, D ^g   Pan, Q ^b   Li, L ^b   Biscotti, C ^a   Dawson, A ^a   Li, A ^b   Wu, L ^b   Ling, Y ^b   Ma, C P ^h   Yang, X P ⁱ  

^a LERNER RESEARCH INSTITUTE   (United States)

^b PEKING UNION MEDICAL COLLEGE   (China)

^c Kaiser Permanente ^*  (United States)

^d Optical Biopsy Tech LLC   (United States)

^e Digene Corporation   (United States)

^f Cytyc Corporation   (United States)

^g NeoPath Inc   (United States)

^h Cancer Hospital   (China)

ⁱ Women and Children Health Station   (China)

Author keywords

Cervical cancer; Cervical intraepithelial neoplasia; Developing countries; Human papillomavirus; Mass screening

Indexed keywords

ADULT; ARTICLE; CANCER SCREENING; CHINA; COLPOSCOPY; DEVELOPING COUNTRY; FEMALE; HIGH RISK PATIENT; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MASS SCREENING; PAPANICOLAOU TEST; PREVALENCE; PRIORITY JOURNAL; SPECTROFLUOROMETRY; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; VAGINA BLEEDING; VAGINA DISCHARGE; WART VIRUS;

EID: 0000735826     PISSN: 1048891X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-1438.1999.99055.x     Document Type: Article

References (18)

1. Clarke EA, Anderson TW. Does screening by "pap" smears help prevent cervical cancer? A case-control study. Lancet 1979;2(8132):1-4.
2. Aristizabal N, Cuello C, Correa P et al. The impact of vaginal cytology of cervical cancer risks in Cali, Colombia. Int J Cancer 1984;34:5-9.
3. Christopherson WM, Lundin FE, Mendez WM et al. Cervical cancer control. A study of morbidity and mortality trends over a twenty-one year period. Cancer 1976;38: 1357-66.
4. Mobius G. Cytological early detection of cervical carcinoma: possibilities and limitations. Analysis of failures. Cancer Res Clin Oncol 1993;119:513-21.
5. Laara E, Day NE, Hakama M. Trends in mortality from cervical cancer in the Nordic countries: association with organized screening programmes. Lancet 1987;1(8544): 1247-49.
6. DeMay RM. Common problems in Papanicolaou smear interpretation. Arch Pathol Lab Med 1997;121:229-38.
7. Linder J, Zahniser D. The ThinPrep Pap test. A review of clinical studies. Acta Cytologica 1997;41:30-8.
8. Birdsong GG. Automated screening of cervical cytology specimens. Hum Pathol 1996;27:468-81.
9. Wright TC, Xiao WS, Koulos J. Comparison of management algorithms for the evaluation of women with low-grade cytologic abnormalities. Obstet Gynecol 1995;85: 202-10.
10. Ramanujam N, Follen Mitchell M, Mahadevan A et al. Development of a multivariate statistical algorithm to analyze human cervical tissue fluorescence spectra acquired in vivo. Lasers Surg Med 1996;19:46-62.
11. Schiffman MH, Bauer HM, Hoover RN et al. Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia. J Natl Cancer Inst 1993;85:958-84.
12. Lorincz AT, Reid R, Jenson AB, Greenberg MD, Lancaster W, Kurman RJ. Human papillomavirus infection of the cervix: relative risk associations of 15 common anogenital types. Obstet Gynecol 1992;79:328-37.
13. Bosch FX, Manos MM, Munoz N et al. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. J Natl Cancer Inst 1995;87:796-802.
14. Lorincz A. Molecular methods for the detection of human papillomavirus infection. Obstet Gynecol Clin North Am 1996;23:707-30.
15. Ferris DG, Wright TC, Litaker MS et al. Comparison of two tests for detecting carcinogenic HPV in Women with Papanicolaou Smear reports of ASCUS and LSIL. J Fam Practice 1998;46:136-41.
16. Nindl I, Lorincz A, Mielzynska I et al. Human papillo-mavirus detection in cervical intraepithelial neoplasia by the second-generation hybrid capture microplate test, comparing two different cervical specimen collection methods. Clin Diag Virol 1998;10:49-56.
17. Miller BA, Ries LAG, Hankey BF et al., eds. Cancer Statistics Review: 1973-89, Bethesda MD National Cancer Institute, US 1992Report no. NIH92-2789.
18. Boyes DA. The value of a Pap smear program and suggestions for its implementation. Cancer 1980;48:613.